Immunovant Inc. (IMVT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immunovant Inc.

    NASDAQ: IMVT · Real-Time Price · USD
    16.37
    -0.77 (-4.49%)
    At close: Sep 08, 2025, 3:59 PM
    16.38
    0.06%
    After-hours: Sep 08, 2025, 06:28 PM EDT

    Immunovant Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 377K 231K 1.32M 1.23M 998K
    Gross Profit
    		 -377K -231K -1.32M -1.23M -998K
    Operating Income
    		 -438.15M -282.71M -198.47M -156.16M -107.79M
    Interest Income
    		 24.73M 24.95M 7.58M n/a n/a
    Pretax Income
    		 -412.95M -258.77M -210.95M -156.81M -107.79M
    Net Income
    		 -413.84M -259.34M -210.96M -156.73M -107.43M
    Selling & General & Admin
    		 77.23M 57.28M 48.02M 54.23M 39.51M
    Research & Development
    		 360.92M 225.43M 160.26M 101.81M 68.6M
    Other Expenses
    		 n/a n/a -253K -781K 328K
    Operating Expenses
    		 438.15M 282.71M 208.28M 156.03M 108.12M
    Interest Expense
    		 n/a n/a 12.48M 655K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a
    Cost & Expenses
    		 438.15M 282.71M 208.28M 156.03M 108.12M
    Income Tax Expense
    		 891K 567K 9K -84K -358K
    Shares Outstanding (Basic)
    		 151.57M 138.1M 123.08M 109.68M 87.76M
    Shares Outstanding (Diluted)
    		 151.57M 138.1M 123.08M 109.68M 87.76M
    EPS (Basic)
    		 -2.73 -1.88 -1.71 -1.43 -1.22
    EPS (Diluted)
    		 -2.73 -1.88 -1.71 -1.43 -1.22
    EBITDA
    		 -412.57M -269.98M -209.63M -155.58M -106.79M
    EBIT
    		 -412.95M -270.21M -210.95M -156.81M -107.79M
    Depreciation & Amortization
    		 377K 231K 1.32M 1.23M 998K

    Add to Watchlist